Publications Database

Malone R. P. et al. (1991)

Repeated episodes of neuroleptic-related dyskinesias in autistic children.

Psychopharmacology Bulletin

27(2), pp. 113-117

Read Abstract (New Window)

Malone R. P. , Waheed A. (2009)

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.

Drugs

69(5), pp. 535-548.

Read Abstract (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

Miral S. et al. (2008)

Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial.

European Child and Adolescent Psychiatry

17(1), pp. 1-8.

Read Abstract (New Window)

Mohiuddin S. , Ghaziuddin M. (2013)

Psychopharmacology of autism spectrum disorders: A selective review.

Autism

17(6), pp. 645-654.

Read Abstract (New Window)

Ornitz E. M. (1985)

Should autistic children be treated with haloperidol?

American Journal of Psychiatry

142(7), pp. 883-884

Perry R. et al. (1989)

Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration.

Journal of the American Academy of Child and Adolescent Psychiatry

28 pp. 87-92

Read Abstract (New Window)

American Society of Health-System Pharmacists (2008)

Haloperidol.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Posey D. J. et al. (2008)

Antipsychotics in the treatment of autism.

Journal of Clinical Investigation

118(1), pp. 6-14

Read Abstract (New Window) Read Full (New Window)

Posey D. J. , McDougle C. J. (2001)

Pharmacotherapeutic management of autism.

Expert Opinion on Pharmacotherapy

2(4), pp. 587-600

Read Abstract (New Window)

Posey D. J. , McDougle C. J. (2000)

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Harvard Review of Psychiatry

8(2), pp. 45-63

Read Abstract (New Window)

Rajapakse T. , Pringsheim T. (2010)

Pharmacotherapeutics of tourette syndrome and stereotypies in autism.

Seminars in Pediatric Neurology

17(4), pp. 254-260

Read Abstract (New Window)

Remington G. et al. (2001)

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.

Journal of Clinical Psychopharmacology

21(4), pp. 440-444

Read Abstract (New Window)

Sanchez L. e. et al. (1995)

A comparison of live and videotape ratings: clomipramine and haloperidol in autism.

Psychopharmacology Bulletin

31(2), pp. 371-378.

Read Abstract (New Window)

Serrano. A. (1981)

Haloperidol: its use in children.

Journal of Clinical Psychiatry

42(4), pp. 154-156

Read Abstract (New Window)

Silva R. R. et al. (1993)

Haloperidol withdrawal and weight changes in autistic children.

Psychopharmacology Bulletin

29(2), pp. 287-291

Read Abstract (New Window)

Spencer E. K. , Alpert M. , Pouget E. (1994)

Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS.

Psychosomatic Medicine

30(2), pp. 199-202

Read Abstract (New Window)

Sung M. et al. (2014)

What's in the pipeline? Drugs in development for autism spectrum disorder.

Neuropsychiatric Disease and Treatment

(10), pp. 371-381.

Read Abstract (New Window) Read Full (New Window)

Tyrer P. et al. (2008)

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.

Lancet

371(9606), pp. 57-63.

Read Abstract (New Window)

Wong S. et al. (1991)

Applying a DRO schedule and compliance training to reduce aggressive and self-injurious behavior in an autistic man: a case report.

Journal of Behavior Therapy and Experimental Psychiatry

22(4), pp. 299-304

Read Abstract (New Window)